Utilization of genomic sequence information to develop malaria vaccines
Author:
Doolan D. L.12, Aguiar J. C.13, Weiss W. R.1, Sette A.4, Felgner P. L.5, Regis D. P.1, Quinones-Casas P.16, Yates J. R.7, Blair P. L.1, Richie T. L.1, Hoffman S. L.1, Carucci D. J.1
Affiliation:
1. Malaria Program, Naval Medical Research Center, Silver Spring, MD 20910-7500, USA 2. Department of Molecular Microbiology and Immunology, School of Hygiene and Public Health, Johns Hopkins University, Baltimore, MD 21205-2179,USA 3. Pan American Health Organization, Washington, DC 20910, USA 4. La Jolla Institute for Allergy and Immunology, San Diego, CA 92121,USA 5. University of California Irvine, Irvine, CA 92697, USA 6. Henry M. Jackson Foundation, Rockville, MD 20852, USA 7. The Scripps Research Institute, La Jolla, CA 92037, USA
Abstract
SUMMARYRecent advances in the fields of genomics, proteomics and molecular immunology offer tremendous opportunities for the development of novel interventions against public health threats, including malaria. However, there is currently no algorithm that can effectively identify the targets of protective T cell or antibody responses from genomic data. Furthermore, the identification of antigens that will stimulate the most effective immunity against the target pathogen is problematic, particularly if the genome is large. Malaria is an attractive model for the development and validation of approaches to translate genomic information to vaccine development because of the critical need for effective anti-malarial interventions and because the Plasmodium parasite is a complex multistage pathogen targeted by multiple immune responses. Sterile protective immunity can be achieved by immunization with radiation-attenuated sporozoites, and anti-disease immunity can be induced in residents in malaria-endemic areas. However, the 23 Mb Plasmodium falciparum genome encodes more than 5300 proteins, each of which is a potential target of protective immune responses. The current generation of subunit vaccines is based on a single or few antigens and therefore might elicit too narrow a breadth of response. We are working towards the development of a new generation vaccine based on the presumption that duplicating the protection induced by the whole organism may require a vaccine nearly as complex as the organism itself. Here, we present our strategy to exploit the genomic sequence of P. falciparum for malaria vaccine development.
Publisher
The Company of Biologists
Subject
Insect Science,Molecular Biology,Animal Science and Zoology,Aquatic Science,Physiology,Ecology, Evolution, Behavior and Systematics
Reference89 articles.
1. Bahl, A., Brunk, B., Crabtree, J., Fraunholz, M. J., Gajria, B.,Grant, G. R., Ginsburg, H., Gupta, D., Kissinger, J. C., Labo, P. et al.(2003). PlasmoDB: the Plasmodium genome resource. A database integrating experimental and computational data. Nucleic Acids Res.31,212-215. 2. Baird, J. (1995). Host age as a determinant of naturally acquired immunity to Plasmodium falciparum. Parasitol. Today11,105-111. 3. Baird, J. K. (1998). Age-dependent characteristics of protection versus susceptibility to Plasmodium falciparum. Ann. Trop. Med. Parasitol.92,367-390. 4. Berzins, K. and Perlmann, P. (1996). Malaria vaccines: attacking infected erythrocytes. In Malaria Vaccine Development: A Multi-Immune Response Approach (ed. S. L Hoffman),pp. 105-144. Washington, DC: ASM Press. 5. Bouharoun-Tayoun, H., Oeuvray, C., Lunel, F. and Druilhe, P.(1995). Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages. J. Exp. Med.182,409-418.
Cited by
58 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Visceral and Tegumentary Leishmaniasis;Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges;2023 2. Stochastic expression of invasion genes in Plasmodium falciparum schizonts;Nature Communications;2022-05-30 3. Vaccines for leishmaniasis and the implications of their development for American tegumentary leishmaniasis;Human Vaccines & Immunotherapeutics;2019-11-11 4. Trematode Genomics and Proteomics;Advances in Experimental Medicine and Biology;2019 5. Vaccine Target Discovery;Encyclopedia of Bioinformatics and Computational Biology;2019
|
|